sepsis – Medxy AI

Shorter Is Often Better: Expert Consensus on Antibiotic Duration in Sepsis and Severe Infections in the ICU

By MedXY 10/22/2026

A 2026 expert consensus recommends shorter, individualized antibiotic courses for most severe infections in critically ill patients, with clear exceptions and guidance on biomarkers, source control, and stewardship.

Critical Care Diabetes & Endocrinology news

Impact of Diabetes and Atherosclerotic Cardiovascular Disease on the Prognostic Role of sTNFR1 in Sepsis Mortality

By MedXY 10/16/2026

This study reveals how diabetes and ASCVD alter the link between soluble TNF receptor 1 levels and 90-day sepsis mortality, informing biomarker-guided risk assessment and understanding of sepsis pathobiology.

Critical Care Infectious Diseases news

White Blood Cell Count as a Predictor of Antibiotic Efficacy in Sepsis: Insights from Comparative Studies of Cefepime and Piperacillin-Tazobactam

By MedXY 10/09/2026

White blood cell count modifies mortality outcomes in sepsis patients treated with cefepime versus piperacillin-tazobactam, suggesting its potential role in guiding antibiotic selection.

Critical Care Infectious Diseases news

International Validation of Sepsis Temperature-Trajectory Subphenotypes Reveals Immune and Coagulation Profiles with Implications for Immunoglobulin Therapy

By MedXY 10/01/2026

This study validates temperature-trajectory sepsis subphenotypes in a large Chinese ICU cohort, linking immune and coagulation dysfunction with mortality and highlighting differential responses to immunoglobulin therapy, particularly benefit in hypothermic patients.

Critical Care Infectious Diseases news

Pre-ICU Balanced Crystalloids Reduce Mortality in Sepsis: Insights from a Large Multicenter Cohort Study

By MedXY 09/23/2026

A large multicenter study shows that balanced crystalloids administered before ICU admission in sepsis patients reduce 30-day mortality compared to saline, supporting early fluid choice's impact on sepsis outcomes.

Critical Care news Respiratory

Evaluating the Impact of Early Mobilization in Mechanically Ventilated ICU Patients with Sepsis or Acute Respiratory Failure: Insights from the EVER Multicenter RCT

By MedXY 09/01/2026

The EVER trial examined if a structured early mobilization protocol improves functional outcomes in ventilated patients with sepsis or respiratory failure. Despite earlier and increased mobilization, no significant functional benefit was observed at ICU discharge or 12 months.

Critical Care news Plastic Surgery

Impact of Early Surgical Excision on Survival in Severe Burns: Insights from a Multicenter Prospective Study

By MedXY 08/18/2026

Early surgical excision within 48 hours significantly lowers 90-day mortality in adults with severe burns, suggesting it as a beneficial strategy despite increased sepsis risk.

Clinical Updates news

Incidence, Outcomes, and Risk Factors for Mortality in Patients With Sepsis in South Korea: Insights From a Nationwide Cohort Study and Related Evidence

By MedXY 08/17/2026

This review synthesizes nationwide epidemiological trends of sepsis in South Korea from 2011 to 2022, elucidating incidence increases, declining in-hospital mortality, and key clinical and socioeconomic mortality determinants alongside relevant complementary studies.

Critical Care news OB/GYN & Women’s Health

Impact of Texas Abortion Ban on Critical Illness in Hospitalized Pregnant Women: A Retrospective Cohort Analysis

By MedXY 08/10/2026

The Texas Senate Bill 8 abortion ban is linked to an increased rate of critical illness, sepsis, and infections among hospitalized pregnant women with high-risk features, highlighting significant implications for maternal healthcare in restrictive states.

Critical Care Nephrology news

H3.1 Nucleosomes as Predictive Biomarkers for Renal Replacement Therapy and Mortality in Sepsis: Insights from the SISPCT Trial

By MedXY 08/07/2026

Elevated plasma levels of H3.1 nucleosomes at ICU admission correlate with increased mortality and acute kidney injury requiring renal replacement therapy in sepsis, highlighting their potential as prognostic biomarkers.

Critical Care Infectious Diseases news

Early Shenfu Injection in Sepsis: Impact on Hemodynamics, Mortality, and Microcirculation in a Multicenter RCT

By MedXY 07/17/2026

Early administration of Shenfu injection in septic ICU patients did not reduce vasopressor use but was associated with lower mortality and improved microcirculation, warranting further validation.

Critical Care Infectious Diseases news

Harnessing Precision Medicine: The APS Consortium’s National Platform for Phenotyping ARDS, Pneumonia, and Sepsis

By MedXY 07/15/2026

The APS Consortium establishes a large, prospective cohort of critically ill adults with ARDS, pneumonia, and sepsis to enable biologically based phenotyping, leveraging rich clinical data and biospecimens for improved understanding and therapeutic development.

Cardiology Critical Care news

Identifying Cardiovascular Subphenotypes in Sepsis: Toward Personalized Hemodynamic Management

By MedXY 07/07/2026

Unsupervised clustering of echocardiographic and hemodynamic data in sepsis reveals four distinct cardiovascular subphenotypes, each with unique mortality risks and responses to treatment, enabling personalized shock management strategies.

Critical Care Internal Medicine news

Comparing Early Restrictive and Liberal Fluid Strategies in Sepsis-Induced Hypotension: Long-Term Effects on Patient-Centered Outcomes

By MedXY 07/05/2026

A randomized trial showed no significant differences in 6- and 12-month cognitive, physical, and quality of life outcomes between early restrictive and liberal fluid resuscitation in sepsis-induced hypotension.

Critical Care Infectious Diseases news

Clinical Metagenomics in Sepsis: Insights from the DigiSep Randomized Controlled Trial

By MedXY 07/02/2026

The DigiSep trial assessed the impact of metagenomic next-generation sequencing (mNGS) on sepsis outcomes. While primary endpoint improvement was not significant, secondary analyses revealed benefits in mechanical ventilation duration, shock resolution, and quality of life without raising healthcare costs.

Critical Care Infectious Diseases news

Impact of Appropriate Antimicrobial Therapy on ICU Patient Outcomes: Subanalysis of the DIANA Study Dataset

By MedXY 06/05/2026

In critically ill ICU patients with confirmed bacterial infections, appropriate empiric antimicrobial therapy was common and independently linked to lower 28-day mortality and more antimicrobial-free days.

Critical Care Infectious Diseases news

Biomarker Signatures in Sepsis: Linking Host Response to Clinical Outcomes

By MedXY 04/28/2026

A prospective cohort study identifies biomarker signatures for host resistance, disease tolerance, and damage in sepsis, revealing associations with mortality and sepsis subtypes.

Critical Care Infectious Diseases news

Cultural Diversity in ICU: A Protective Factor Against Sepsis Mortality

By MedXY 04/24/2026

A multicenter study reveals that culturally and linguistically diverse patients with sepsis had lower in-hospital mortality and shorter ICU stays compared to non-CaLD patients, challenging prior assumptions about healthcare disparities.

Critical Care Emergency Medicine news

Rethinking Shock Management: From Standardized Protocols to Personalized Precision Medicine

By MedXY 03/19/2026

Expert consensus highlights a shift in shock treatment, emphasizing that standardized protocols must give way to personalized, physiology-driven bedside care to prevent iatrogenic injury and improve survival.

Critical Care Diabetes & Endocrinology news

Precision Prognostics in Sepsis: How Stress Hyperglycemia and Glucose Variability Define Mortality Risk Across Metabolic Profiles

By MedXY 02/04/2026

This study reveals that combining stress hyperglycemia ratio and glucose variability significantly improves mortality prediction in sepsis, with risk patterns varying significantly based on a patient's baseline metabolic status (Normal, Pre-DM, or DM).